Anti-BPIA1/ BPIFA1/ LUNX functional antibody

Anti-BPIA1/ BPIFA1/ LUNX functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to BPIFA1/BPIFA1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0690-Ab-1/ GM-Tg-hg-SE0690-Ab-2Anti-Human BPIFA1 monoclonal antibodyHuman
GM-Tg-rg-SE0690-Ab-1/ GM-Tg-rg-SE0690-Ab-2Anti-Rat BPIFA1 monoclonal antibodyRat
GM-Tg-mg-SE0690-Ab-1/ GM-Tg-mg-SE0690-Ab-2Anti-Mouse BPIFA1 monoclonal antibodyMouse
GM-Tg-cynog-SE0690-Ab-1/ GM-Tg-cynog-SE0690-Ab-2Anti-Cynomolgus/ Rhesus macaque BPIFA1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0690-Ab-1/ GM-Tg-felg-SE0690-Ab-2Anti-Feline BPIFA1 monoclonal antibodyFeline
GM-Tg-cang-SE0690-Ab-1/ GM-Tg-cang-SE0690-Ab-2Anti-Canine BPIFA1 monoclonal antibodyCanine
GM-Tg-bovg-SE0690-Ab-1/ GM-Tg-bovg-SE0690-Ab-2Anti-Bovine BPIFA1 monoclonal antibodyBovine
GM-Tg-equg-SE0690-Ab-1/ GM-Tg-equg-SE0690-Ab-2Anti-Equine BPIFA1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0690-Ab-1/ GM-Tg-hg-SE0690-Ab-2; GM-Tg-rg-SE0690-Ab-1/ GM-Tg-rg-SE0690-Ab-2;
GM-Tg-mg-SE0690-Ab-1/ GM-Tg-mg-SE0690-Ab-2; GM-Tg-cynog-SE0690-Ab-1/ GM-Tg-cynog-SE0690-Ab-2;
GM-Tg-felg-SE0690-Ab-1/ GM-Tg-felg-SE0690-Ab-2; GM-Tg-cang-SE0690-Ab-1/ GM-Tg-cang-SE0690-Ab-2;
GM-Tg-bovg-SE0690-Ab-1/ GM-Tg-bovg-SE0690-Ab-2; GM-Tg-equg-SE0690-Ab-1/ GM-Tg-equg-SE0690-Ab-2
Products NameAnti-BPIFA1 monoclonal antibody
Formatmab
Target NameBPIFA1
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-BPIFA1 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0690-Ag-1Recombinant multi-species BPIA1/ BPIFA1/ LUNX protein
    ORF Viral VectorpGMLPm003497mouse Bpifa1 Lentivirus plasmid
    ORF Viral VectorvGMLPm003497mouse Bpifa1 Lentivirus particle


    Target information

    Target IDGM-SE0690
    Target NameBPIFA1
    Gene ID51297,18843,246238,714509,609982,101091273,281989,100068890
    Gene Symbol and SynonymsbA49G10.5,BPIFA1,LUNX,NASG,PLUNC,SPLUNC1,SPURT
    Uniprot AccessionQ9NP55,Q8K4I4,Q8SPU5
    Uniprot Entry NameBPIA1_HUMAN,BPIA1_RAT,BPIA1_BOVIN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseLung Cancer
    Gene EnsemblENSG00000198183
    Target ClassificationN/A

    The target: BPIFA1, gene name: BPIFA1, also named as LUNX, NASG, PLUNC, SPLUNC1, SPURT, bA49G10.5. This gene is the human homolog of murine plunc, and like the mouse gene, is specifically expressed in the upper airways and nasopharyngeal regions. The encoded antimicrobial protein displays antibacterial activity against Gram-negative bacteria. It is thought to be involved in inflammatory responses to irritants in the upper airways and may also serve as a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer. Multiple transcript variants resulting from alternative splicing in the 3' UTR have been detected, but the full-length nature of only three are known. [provided by RefSeq, Aug 2014].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.